Literature DB >> 18395608

Modulation of vascular endothelial growth factor (VEGF) expression in motor neurons and its electrophysiological effects.

Daniel P McCloskey1, Tana M Hintz, Helen E Scharfman.   

Abstract

Previous studies have shown that VEGF expression in forebrain increases after experimental manipulations that increase neuronal activity. One question is whether this also occurs in motor neurons. If so, it could be potentially advantageous from a therapeutic perspective, because VEGF prevents motor neuron degeneration. Therefore, we asked whether endogenous VEGF expression in motor neurons could be modulated. We also asked how VEGF exposure would influence motor neurons using electrophysiology. Immunocytochemistry showed that motor neuron VEGF expression increased after a stimulus that increases neuronal and motor activity, i.e., convulsive seizures. The increase in VEGF immunoreactivity occurred in all motor neuron populations that were examined 24h later. This effect was unlikely to be due to seizure-induced toxicity, because silver degeneration stain did not show the typical appearance of a dying or dead neuron. To address the effects of VEGF on motor neuron function, VEGF was applied directly to motor neurons while recording intracellularly, using a brainstem slice preparation. Exposure to exogenous VEGF (200 ng/ml) in normal conditions depressed stimulus-evoked depolarization of hypoglossal motor neurons. There was no detectable effect of VEGF on membrane properties or firing behavior. We suggest that VEGF is upregulated in neurons when they are strongly activated, and VEGF depresses neuronal excitation as a compensatory mechanism. Failure of this mechanism may contribute to diseases that involve a dysregulation of VEGF, excessive excitation of motor neurons, and motor neuron loss, such as amyotrophic lateral sclerosis (ALS).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18395608      PMCID: PMC2422999          DOI: 10.1016/j.brainresbull.2007.11.018

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  28 in total

1.  Structural and functional asymmetry in the normal and epileptic rat dentate gyrus.

Authors:  Helen E Scharfman; Anne L Sollas; Karen L Smith; Meyer B Jackson; Jeffrey H Goodman
Journal:  J Comp Neurol       Date:  2002-12-23       Impact factor: 3.215

2.  Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.

Authors:  B Oosthuyse; L Moons; E Storkebaum; H Beck; D Nuyens; K Brusselmans; J Van Dorpe; P Hellings; M Gorselink; S Heymans; G Theilmeier; M Dewerchin; V Laudenbach; P Vermylen; H Raat; T Acker; V Vleminckx; L Van Den Bosch; N Cashman; H Fujisawa; M R Drost; R Sciot; F Bruyninckx; D J Hicklin; C Ince; P Gressens; F Lupu; K H Plate; W Robberecht; J M Herbert; D Collen; P Carmeliet
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

3.  VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.

Authors:  Diether Lambrechts; Erik Storkebaum; Masafumi Morimoto; Jurgen Del-Favero; Frederik Desmet; Stefan L Marklund; Sabine Wyns; Vincent Thijs; Jörgen Andersson; Ingrid van Marion; Ammar Al-Chalabi; Stephanie Bornes; Rhiannon Musson; Valerie Hansen; Lars Beckman; Rolf Adolfsson; Hardev Singh Pall; Hervé Prats; Severine Vermeire; Paul Rutgeerts; Shigehiro Katayama; Takuya Awata; Nigel Leigh; Loïc Lang-Lazdunski; Mieke Dewerchin; Christopher Shaw; Lieve Moons; Robert Vlietinck; Karen E Morrison; Wim Robberecht; Christine Van Broeckhoven; Désiré Collen; Peter M Andersen; Peter Carmeliet
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

4.  Fluoro-jade B stains quiescent and reactive astrocytes in the rodent spinal cord.

Authors:  Kevin J Anderson; Isabella Fugaccia; Stephen W Scheff
Journal:  J Neurotrauma       Date:  2003-11       Impact factor: 5.269

5.  Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration.

Authors:  Bryce L Sopher; Patrick S Thomas; Michelle A LaFevre-Bernt; Ida E Holm; Scott A Wilke; Carol B Ware; Lee-Way Jin; Randell T Libby; Lisa M Ellerby; Albert R La Spada
Journal:  Neuron       Date:  2004-03-04       Impact factor: 17.173

6.  Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus.

Authors:  J N Nicoletti; S K Shah; D P McCloskey; J H Goodman; A Elkady; H Atassi; D Hylton; J S Rudge; H E Scharfman; S D Croll
Journal:  Neuroscience       Date:  2007-10-26       Impact factor: 3.590

Review 7.  Hypoxia-induced angiogenesis during carcinogenesis.

Authors:  Kyu-Sil Choi; Moon-Kyoung Bae; Joo-Won Jeong; Hyo-Eun Moon; Kyu-Won Kim
Journal:  J Biochem Mol Biol       Date:  2003-01-31

8.  VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia.

Authors:  Yunjuan Sun; Kunlin Jin; Lin Xie; Jocelyn Childs; Xiao Ou Mao; Anna Logvinova; David A Greenberg
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 9.  Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.

Authors:  Paul R Heath; Pamela J Shaw
Journal:  Muscle Nerve       Date:  2002-10       Impact factor: 3.217

10.  Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors.

Authors:  Samuel S Newton; Emily F Collier; Joshua Hunsberger; David Adams; Rose Terwilliger; Emmanuel Selvanayagam; Ronald S Duman
Journal:  J Neurosci       Date:  2003-11-26       Impact factor: 6.167

View more
  14 in total

1.  VEGF ameliorates cognitive impairment in in vivo and in vitro ischemia via improving neuronal viability and function.

Authors:  Jiajia Yang; Yang Yao; Ting Chen; Tao Zhang
Journal:  Neuromolecular Med       Date:  2013-12-14       Impact factor: 3.843

Review 2.  VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases.

Authors:  Yun-Zheng Le
Journal:  Vision Res       Date:  2017-06-21       Impact factor: 1.886

Review 3.  Estrogen-growth factor interactions and their contributions to neurological disorders.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Headache       Date:  2008-07       Impact factor: 5.887

4.  Investigation of the mechanisms of VEGF-mediated compensatory lung growth: the role of the VEGF heparin-binding domain.

Authors:  Lumeng J Yu; Victoria H Ko; Duy T Dao; Jordan D Secor; Amy Pan; Bennet S Cho; Paul D Mitchell; Hiroko Kishikawa; Diane R Bielenberg; Mark Puder
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

5.  Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions.

Authors:  Timothy J Seabrook; Amanda Littlewood-Evans; Volker Brinkmann; Bernadette Pöllinger; Christian Schnell; Peter C Hiestand
Journal:  J Neuroinflammation       Date:  2010-12-22       Impact factor: 8.322

6.  Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients.

Authors:  Pawan K Gupta; Sudesh Prabhakar; Suresh Sharma; Akshay Anand
Journal:  J Neuroinflammation       Date:  2011-05-13       Impact factor: 8.322

Review 7.  Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Francesco Girolamo; Cristiana Coppola; Domenico Ribatti; Maria Trojano
Journal:  Acta Neuropathol Commun       Date:  2014-07-22       Impact factor: 7.801

Review 8.  Emerging roles for semaphorins and VEGFs in synaptogenesis and synaptic plasticity.

Authors:  Miguel Tillo; Christiana Ruhrberg; Francesca Mackenzie
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

9.  Neural progenitor cell implants modulate vascular endothelial growth factor and brain-derived neurotrophic factor expression in rat axotomized neurons.

Authors:  Rocío Talaverón; Esperanza R Matarredona; Rosa R de la Cruz; Angel M Pastor
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

Review 10.  ALS and oxidative stress: the neurovascular scenario.

Authors:  Akshay Anand; Keshav Thakur; Pawan Kumar Gupta
Journal:  Oxid Med Cell Longev       Date:  2013-12-03       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.